Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors
Allison Quick(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Anne M. Noonan(The Ohio State University), Robert Wesolowski(The Ohio State University Wexner Medical Center), Nicole Williams(The Ohio State University), Daniel G. Stover(Harvard University), Filadelfiya Zvinovski(The Ohio State University Wexner Medical Center), Jeffrey VanDeusen(The Ohio State University), Sagar Sardesai(The Ohio State University Wexner Medical Center), Elizabeth Arthur(The Ohio State University Wexner Medical Center), Bhuvaneswari Ramaswamy(The Ohio State University), Raquel E. Reinbolt(The Ohio State University), Karen L. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stephanie S. Faubion(Jacksonville College), Anupama Suresh(The Ohio State University Wexner Medical Center), Catherine O. Hudson(Institute for Female Pelvic Medicine and Reconstructive Surgery), Cynthia Evans(Eli Lilly (United States)), Charles L. Loprinzi(Mayo Clinic in Arizona), Andrew F. Hundley(The Ohio State University Wexner Medical Center), Julie Stephens(The Ohio State University)
Cited by 43
Related Papers
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
|Nature|2016|629
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
|Journal of Clinical Oncology|2005|565